FDA inspection
Xellia Pharmaceuticals ApS: FDA inspection ending Oct 16, 2012
FDA inspection 806442 · Voluntary Action Indicated (VAI) · Copenhagen S
Key facts
| Inspection ID | 806442 |
|---|---|
| Firm | Xellia Pharmaceuticals ApS |
| FEI number | 3002806860 |
| Address | Dalslandsgade 11 |
| City | Copenhagen S |
| Country | Denmark |
| Fiscal year | 2013 |
| Inspection end date | Oct 16, 2012 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data